Company: VRCA
Filing Date: 2025-07-01
Form Type: 8-K
Source: 0001193125-25-153471
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-07-01
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01      Regulation FD Disclosure.  

On July 1, 2025, the Company issued a press release announcing the Second Amendment. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form8-K.

In accordance with General Instruction B.2. of Form 8-K, theinformation in this Item 7.01, and Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant’s filings under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.